Related Experiment Video
Updated: Jun 24, 2026
12:48
Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions
Published on: January 7, 2019
Cardiovascular regeneration: pushing and pulling on progenitors
Matthew L Steinhauser1, Richard T Lee
1Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115-6110, USA.
Cell Stem Cell
|April 4, 2009
Summary
This study presents a novel pharmacoregenerative strategy for myocardial infarction. By mobilizing bone marrow progenitors and preserving SDF-1, researchers improved heart function and progenitor cell recruitment.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Stem Cell Biology
Background:
- Myocardial infarction (MI) leads to significant heart damage and functional decline.
- Current treatments for MI have limitations in promoting cardiac repair.
- Mobilizing endogenous stem cells offers a promising therapeutic avenue.
Discussion:
- Zaruba et al. (2009) developed a dual-action strategy for MI treatment.
- Granulocyte-colony stimulating factor (G-CSF) was used to mobilize hematopoietic stem and progenitor cells from bone marrow.
- Protease inhibition was employed to prevent the degradation of stromal cell-derived factor-1 (SDF-1), a key homing chemokine.
Key Insights:
- The combined approach significantly enhanced the recruitment of progenitor cells to the injured heart.
- This increased recruitment led to measurable improvements in cardiac function post-MI.
- The study demonstrates the potential of pharmacoregeneration for treating heart disease.
Outlook:
- This strategy could pave the way for new regenerative therapies for cardiovascular diseases.
- Further research may explore optimizing G-CSF dosage and protease inhibitors for clinical application.
- Investigating long-term effects and efficacy in different MI models is warranted.
Related Concept Videos
01:19Overview of Regeneration and Repair
Regeneration and repair processes are critical in healing damages caused by injury, disease, and aging. In regeneration, the damaged tissue is entirely replaced with new growth that restores the original architecture and function. In contrast, tissue repair usually results in a fixed tissue architecture involving scar formation. Scars generally do not reestablish tissue function and may also exhibit structural abnormalities at the injury site.
Regeneration
All animals have varying degrees of...
Regeneration
All animals have varying degrees of...
01:33Whole Body Regeneration
Regeneration is the process of restoring injured or lost tissues, organs, or body parts. While simpler organisms generally show greater ability to regenerate their whole body, few complex animals show similarly exceptional regeneration. For example, planarian flatworms have a unique regenerative potential making them a popular study organism among biologists to understand the mechanisms of whole body regeneration. Other organisms, such as hydra, also show extreme regeneration potential; even...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:23Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:15Neurogenesis and Regeneration of Nervous Tissue
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...